Plunkett Research Online: Anchiano Therapeutics Ltd

ANCHIANO THERAPEUTICS LTD (ANCN) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Anchiano Therapeutics Ltd. is a preclinical biotechnology company that discovers and develops new cancer therapies designed to target the products of mutated genes that drive human malignancies. The firm’s therapies are small molecule targeted therapeutics, the first of which inhibits the products .....


ANCHIANO THERAPEUTICS LTD

Ticker: ANCN
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 972-2-548-6555
Fax: 972-2-548-6550
Address: 5 Kiryat Hamada St., Har Hotzvim
Jerusalem, 9777401 Israel

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Frank G. Haluska CEO
Jonathan Burgin CFO
See More
Anchiano Therapeutics Ltd. is a preclinical biotechnology company that discovers and develops new cancer therapies designed to target the products of mutated genes that drive human malignancies. The firm’s therapies are small molecule targeted therapeutics, the first of which inhibits the products .....See More See More

$USD, In whole numbers 2019 2018 2017 2016 2015 2014 2013
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture